|17th September 2020||Ron Cohen||8,543||Grant/award etc.||$0.00|
|17th September 2020||Burkhard Blank||3,015||Grant/award etc.||$0.00|
|17th September 2020||David Lawrence||3,015||Grant/award etc.||$0.00|
|17th September 2020||Lauren M Sabella||3,015||Grant/award etc.||$0.00|
|20th August 2020||Andrew A. Hindman||4,323||Payment by withholding||$18.22||$78,765.06|
|27th July 2020||Andrew A. Hindman||20,000||Grant/award etc.||$0.00|
|20th February 2020||Andrew A. Hindman||7,060||Payment by withholding||$25.90||$182,854.00|
|3rd February 2020||Andrew A. Hindman||20,000||Grant/award etc.||$0.00|
|3rd February 2020||Andrew A. Hindman||43,550||Grant/award etc.||$0.00|
|2nd December 2019||Jane Wasman||2,227||Open or private sale||$1.60||$3,552.73|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.